{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:48:36Z","timestamp":1792147716597,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-130239"],"award-info":[{"award-number":["R01-130239"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpet.2026.105036","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:07:14Z","timestamp":1790687234000},"page":"105036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From stress cytokine to drug target: The translational landscape of growth differentiation factor 15"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-7841","authenticated-orcid":false,"given":"Nicholas R.","family":"Najjar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9782-6551","authenticated-orcid":false,"given":"Matthew R.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-5656","authenticated-orcid":false,"given":"Robert P.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.jpet.2026.105036_bib1","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s004410051337","article-title":"Expression of a novel member of the TGF-beta superfamily, growth\/differentiation factor-15\/macrophage-inhibiting cytokine-1 (GDF-15\/MIC-1) in adult rat tissues","volume":"297","author":"B\u00f6ttner","year":"1999","journal-title":"Cell Tissue Res"},{"issue":"9","key":"10.1016\/j.jpet.2026.105036_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/jcmm.17725","article-title":"Overview of growth differentiation factor 15 in metabolic syndrome","volume":"27","author":"Asrih","year":"2023","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.105036_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tem.2024.09.002","article-title":"GDF15 is still a mystery hormone","volume":"36","author":"Sigvardsen","year":"2025","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jpet.2026.105036_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa007","article-title":"GDF15: a hormone conveying somatic distress to the brain","volume":"41","author":"Lockhart","year":"2020","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.jpet.2026.105036_bib6","article-title":"Physiological role of serum growth differentiation factor-15 (GDF-15) level and iron metabolism in community-dwelling older adults","volume":"16","author":"Fukuda","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jpet.2026.105036_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.jpet.2026.105036_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat Med"},{"issue":"7675","key":"10.1016\/j.jpet.2026.105036_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jpet.2026.105036_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.jpet.2026.105036_bib12","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jpet.2026.105036_bib13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/nu16050734","article-title":"GFRAL is widely distributed in the brain and peripheral tissues of mice","volume":"16","author":"Fichtner","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cne.903060107","article-title":"Subregional topography of capillaries in the dorsal vagal complex of rats: II. physiological properties","volume":"306","author":"Gross","year":"1991","journal-title":"J Comp Neurol"},{"issue":"16","key":"10.1016\/j.jpet.2026.105036_bib15","doi-asserted-by":"crossref","first-page":"11237","DOI":"10.1021\/acs.jmedchem.3c00667","article-title":"Creation of a peptide antagonist of the GFRAL-RET receptor complex for the treatment of GDF15-induced malaise","volume":"66","author":"Borner","year":"2023","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.jpet.2026.105036_bib16","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-25-0322","article-title":"RET receptor tyrosine kinase architecture, assemblies, and activation","volume":"33","author":"Zol-Hanlon","year":"2026","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jpet.2026.105036_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jpet.2026.105036_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2025.171367","article-title":"The role of leptin and ghrelin in the regulation of appetite in obesity","volume":"186","author":"Skoracka","year":"2025","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2009.10.009","article-title":"Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation","volume":"11","author":"Hayes","year":"2010","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jpet.2026.105036_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116809","article-title":"Overview of growth differentiation factor 15 (GDF15) in metabolic diseases","volume":"176","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.jpet.2026.105036_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3892\/ol.2023.14049","article-title":"Role of growth differentiation factor 15 in cancer cachexia (review)","volume":"26","author":"Ling","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jpet.2026.105036_bib23","first-page":"0832","article-title":"Emerging roles of GDF15 in metabolic and cardiovascular diseases","volume":"8","author":"Tian","year":"2025","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.jpet.2026.105036_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pharmthera.2019.02.008","article-title":"Growth differentiation factor 15 (GDF15): a survival protein with therapeutic potential in metabolic diseases","volume":"198","author":"Baek","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2017.08.096","article-title":"Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice","volume":"498","author":"Li","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.jpet.2026.105036_bib26","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/s12276-026-01727-x","article-title":"De novo and scaffold-based design of GDF15 binders for cancer cachexia diagnostics and therapeutics","volume":"58","author":"Ahn","year":"2026","journal-title":"Exp Mol Med"},{"issue":"24","key":"10.1016\/j.jpet.2026.105036_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70251","article-title":"Targeting the GDF15 signalling for obesity treatment: recent advances and emerging challenges","volume":"28","author":"Zhang","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"7996","key":"10.1016\/j.jpet.2026.105036_bib28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41586-023-06921-9","article-title":"GDF15 linked to maternal risk of nausea and vomiting during pregnancy","volume":"625","author":"Fejzo","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib29","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1038\/s41598-021-87959-5","article-title":"Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation","volume":"11","author":"Fung","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jpet.2026.105036_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400961","article-title":"GDF15 analogues acting as GFRAL ligands","volume":"20","author":"Di Santo","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jpet.2026.105036_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171063","article-title":"Identification of GDF15 peptide fragments inhibiting GFRAL receptor signaling","volume":"168","author":"Alexopoulou","year":"2023","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.jpet.2026.105036_bib32","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s42255-024-01135-3","article-title":"Identification and characterization of human GDF15 knockouts","volume":"6","author":"Gurtan","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.jpet.2026.105036_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1619387","article-title":"Serum GDF15 level as predictive biomarker of clinical outcome in patients with unresectable hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy","volume":"16","author":"Xing","year":"2025","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jpet.2026.105036_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.trecan.2025.06.007","article-title":"GDF15: from biomarker to target in cancer cachexia","volume":"11","author":"H\u00fcllwegen","year":"2025","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MOL.0000000000001025","article-title":"Beyond cellular distress: reframing GDF15 as a lipid-sensitive metabolic signal","volume":"37","author":"Wang","year":"2026","journal-title":"Curr Opin Lipidol"},{"issue":"13","key":"10.1016\/j.jpet.2026.105036_bib36","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.3390\/ijms26136486","article-title":"Levels of growth differentiation factor 15 correlated with metabolic dysfunction-associated steatotic liver disease in children","volume":"26","author":"Mosca","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/apt.18063","article-title":"Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis","volume":"60","author":"Kumazaki","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jpet.2026.105036_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jpm16010016","article-title":"Growth differentiation factor-15 as an emerging biomarker in cardiology: diagnostic and prognostic implications","volume":"16","author":"Lombardi","year":"2026","journal-title":"J Pers Med"},{"key":"10.1016\/j.jpet.2026.105036_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116475","article-title":"Growth and differentiation factor-15: a link between inflammaging and cardiovascular disease","volume":"174","author":"Ny\u00e1r\u00e1dy","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"10.1016\/j.jpet.2026.105036_bib41","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3748\/wjg.v30.i13.1899","article-title":"Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease","volume":"30","author":"Tonkic","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jpet.2026.105036_bib42","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/biomedicines13071589","article-title":"Investigating the role of GDF-15 in diabetes and obesity: a comprehensive analysis of a cohort from the KDEP study","volume":"13","author":"Abubaker","year":"2025","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-09-0417","article-title":"Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet","volume":"161","author":"Dost\u00e1lov\u00e1","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jpet.2026.105036_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fcvm.2020.00103","article-title":"Serum GDF15, a promising biomarker in obese patients undergoing heart surgery","volume":"7","author":"Sarkar","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib45","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-25-0010","article-title":"Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery","volume":"266","author":"Urones","year":"2025","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jpet.2026.105036_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101569","article-title":"GDF15, an emerging key player in human aging","volume":"75","author":"Conte","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jpet.2026.105036_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111228","article-title":"GDF15 as a biomarker of ageing","volume":"146","author":"Liu","year":"2021","journal-title":"Exp Gerontol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10522-024-10165-z","article-title":"GDF-15 as a proxy for epigenetic aging: associations with biological age markers, and physical function","volume":"26","author":"Torrens-Mas","year":"2024","journal-title":"Biogerontology"},{"key":"10.1016\/j.jpet.2026.105036_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/alz70861_108994","article-title":"GDF15 protein as a complementary pathology biomarker of Alzheimer\u2019s disease","volume":"21","author":"Paes","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jpet.2026.105036_bib50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbi.2024.12.010","article-title":"GDF15-GFRAL signaling drives weight loss and lipid metabolism in mouse model of amyotrophic lateral sclerosis","volume":"124","author":"Cocozza","year":"2025","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpet.2026.105036_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/alz.089335","article-title":"GDF15 as a prognostic biomarker of cognitive decline in frontotemporal dementia","volume":"20","author":"Chen","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jpet.2026.105036_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1514518","article-title":"A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration","volume":"15","author":"Isik","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2502","article-title":"Diagnostic utility of GDF15 in neurodegenerative diseases: a systematic review and meta-analysis","volume":"12","author":"Xue","year":"2022","journal-title":"Brain Behav"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41590-025-02406-1","article-title":"A GDF-15-GFRAL axis controls autoimmune T cell responses during neuroinflammation","volume":"27","author":"Sonner","year":"2026","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib55","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000675","article-title":"Growth differentiation factor 15 is increased in stable MS","volume":"7","author":"Amstad","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/acn3.70209","article-title":"Growth differentiation factor 15 elevation in the central nervous system is associated with failure to thrive in Alexander disease","volume":"13","author":"Hagemann","year":"2026","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jpet.2026.105036_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111446","article-title":"The effect of the number of psychiatric hospitalizations and diagnosis in serum levels of CCL11 and GDF15 in individuals with stable schizophrenia, bipolar disorder, and major depressive disorder: the compass between neuro and somatoprogression","volume":"141","author":"Costanzi","year":"2025","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib58","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18632\/oncotarget.6205","article-title":"GDF15 promotes EMT and metastasis in colorectal cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpet.2026.105036_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.564785","article-title":"SCAP mediated GDF15-induced invasion and EMT of esophageal cancer","volume":"10","author":"Dong","year":"2020","journal-title":"Front Oncol"},{"issue":"55","key":"10.1016\/j.jpet.2026.105036_bib60","doi-asserted-by":"crossref","first-page":"94393","DOI":"10.18632\/oncotarget.21765","article-title":"Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling","volume":"8","author":"Peake","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib61","doi-asserted-by":"crossref","first-page":"C557","DOI":"10.1152\/ajpcell.00230.2024","article-title":"Growth differentiation factor 15 is a glucose-downregulated gene acting as the cross talk between stroma and cancer cells of the human bladder","volume":"328","author":"Chang","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jpet.2026.105036_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep21681","article-title":"Combined secretomics and transcriptomics revealed cancer-derived GDF15 is involved in diffuse-type gastric cancer progression and fibroblast activation","volume":"6","author":"Ishige","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2026.105036_bib63","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/1471-2407-14-578","article-title":"Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.jpet.2026.105036_bib64","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-11-0715","article-title":"Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer","volume":"17","author":"Staff","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.jpet.2026.105036_bib65","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","article-title":"Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer","volume":"15","author":"Brown","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41392-025-02331-7","article-title":"Cancer cachexia: molecular basis and therapeutic advances","volume":"11","author":"Tan","year":"2026","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib67","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1038\/s41467-026-72932-5","article-title":"Tumor-derived GDF15 induces CCN3+ Schwann cells to promote cancer pain in pancreatic cancer","volume":"17","author":"Chen","year":"2026","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jpet.2026.105036_bib68","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/biomedicines13081931","article-title":"The multifaceted role of growth differentiation factor 15 (GDF15): a narrative review from cancer cachexia to target therapy","volume":"13","author":"Filippini","year":"2025","journal-title":"Biomedicines"},{"issue":"27","key":"10.1016\/j.jpet.2026.105036_bib69","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1038\/sj.onc.1205610","article-title":"Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1","volume":"21","author":"Albertoni","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","article-title":"GDF15 induces anorexia through nausea and emesis","volume":"31","author":"Borner","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jpet.2026.105036_bib71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cytogfr.2026.01.004","article-title":"GDF15 in the tumor microenvironment: a central mediator of cancer immunometabolism and therapeutic resistance","volume":"88","author":"Lu","year":"2026","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"10.1016\/j.jpet.2026.105036_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002787","article-title":"GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jpet.2026.105036_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.116109","article-title":"Inhibition of GDF15\/GFRAL: a novel opportunity for the treatment of solid tumors","volume":"170","author":"Zhang","year":"2026","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2026.105036_bib74","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood-2016-01-696617","article-title":"GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5\/TGF-\u03b2RII heterodimer","volume":"128","author":"Artz","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib75","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","article-title":"Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment","volume":"14","author":"Haake","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2026.105036_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1680838","article-title":"Combination of PD-1\/PD-L1 and CTLA-4 inhibitors in the treatment of cancer \u2013 a brief update","volume":"16","author":"Park","year":"2025","journal-title":"Front Immunol"},{"issue":"8048","key":"10.1016\/j.jpet.2026.105036_bib77","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41586-024-08305-z","article-title":"Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours","volume":"637","author":"Melero","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2026.105036_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102322","article-title":"Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation","volume":"52","author":"Wang","year":"2022","journal-title":"Redox Biol"},{"issue":"5","key":"10.1016\/j.jpet.2026.105036_bib79","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jcmgh.2023.07.009","article-title":"GDF15 ameliorates liver fibrosis by metabolic reprogramming of macrophages to acquire nflammatory properties","volume":"16","author":"Li","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib80","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/iep.12398","article-title":"Identification of growth differentiation factor 15 as a pro-fibrotic factor in mouse liver fibrosis progression","volume":"102","author":"Qi","year":"2021","journal-title":"Int J Exp Pathol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib81","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70516","article-title":"GDF-15 levels in cirrhosis are linked to hepatic fibrogenesis, bacterial translocation, and worse clinical outcomes","volume":"46","author":"Hofer","year":"2026","journal-title":"Liver Int"},{"key":"10.1016\/j.jpet.2026.105036_bib82","article-title":"Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: potential role in cardiovascular diseases","volume":"9","author":"di Candia","year":"2021","journal-title":"Am Heart J Cardiol Res Pract"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63880-5","article-title":"Growth\/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration","volume":"14","author":"Dogon","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jpet.2026.105036_bib84","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3390\/ijms26052039","article-title":"GDF15 circulating levels are associated with metabolic-associated liver injury and atherosclerotic cardiovascular disease","volume":"26","author":"Girona","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2026.105036_bib85","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v32.i5.115439","article-title":"Growth differentiation factor 15 \u2013 a new molecular target in inflammatory bowel disease: progress and challenges","volume":"32","author":"Yang","year":"2026","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000535089","article-title":"Research progress on the role and mechanism of GDF15 in body weight regulation","volume":"17","author":"Dong","year":"2024","journal-title":"Obes Facts"},{"issue":"7968","key":"10.1016\/j.jpet.2026.105036_bib87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","article-title":"GDF15 promotes weight loss by enhancing energy expenditure in muscle","volume":"619","author":"Wang","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jpet.2026.105036_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034868","article-title":"Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets","volume":"7","author":"Macia","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jpet.2026.105036_bib89","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/dom.14663","article-title":"Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms","volume":"24","author":"Ghidewon","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib90","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/clinem\/dgae550","article-title":"A growth differentiation factor 15 receptor agonist in randomized placebo-controlled trials in healthy or obese persons","volume":"110","author":"Smith","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpet.2026.105036_bib91","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2337\/db22-235-LB","article-title":"235-LB: YH34160, a novel long-acting GDF15 fusion protein, exerts potent and sustained body weight loss in rodent obesity models","volume":"71","author":"Lim","year":"2022","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14886","article-title":"Central mechanisms of emesis: a role for GDF15","volume":"37","author":"Borner","year":"2025","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib93","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/erv.70018","article-title":"GDF15 is elevated in eating disorders and is involved in the gut-brain axis via ghrelin","volume":"34","author":"Tarchi","year":"2026","journal-title":"Eur Eat Disord Rev"},{"key":"10.1016\/j.jpet.2026.105036_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/inm3.70015","article-title":"GDF15: anxiety signalling from the adipose tissue","volume":"2","author":"Zhang","year":"2026","journal-title":"iNew Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.105036_bib95","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2024.04.006","article-title":"Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes","volume":"30","author":"Fejzo","year":"2024","journal-title":"Trends Mol Med"},{"issue":"7","key":"10.1016\/j.jpet.2026.105036_bib96","first-page":"17","article-title":"GDF15 targeting for treatment of hyperemesis gravidarum","volume":"11","author":"Thygerson","year":"2024","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jpet.2026.105036_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102070","article-title":"GDNF family receptor alpha-like (GFRAL) expression is restricted to the caudal brainstem","volume":"91","author":"Hes","year":"2025","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cmet.2022.12.011","article-title":"Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist","volume":"35","author":"Benichou","year":"2023","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib101","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cmet.2023.01.001","article-title":"Activity-balanced GLP-1\/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.jpet.2026.105036_bib102","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/cts.13543","article-title":"A long-acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate model","volume":"16","author":"Zheng","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"6","key":"10.1016\/j.jpet.2026.105036_bib104","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jpet.2026.105036_bib105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12951-025-03182-8","article-title":"Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles","volume":"23","author":"Zou","year":"2025","journal-title":"J Nanobiotechnology"},{"issue":"24","key":"10.1016\/j.jpet.2026.105036_bib106","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpet.2026.105036_bib107","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.PANCA22-PR006","article-title":"Abstract PR006: initial results of a cohort of advanced pancreatic cancer patients in a phase 1b Study of NGM120, a first-in-class anti-GDNF Family Receptor Alpha Like (GFRAL) antibody","volume":"82","author":"Hendifar","year":"2022","journal-title":"Cancer Res"},{"issue":"8_Supplement_1","key":"10.1016\/j.jpet.2026.105036_bib110","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1158\/1538-7445.AM2025-6078","article-title":"Abstract 6078: GFS202A, a novel GDF15\u00d7IL-6 bispecific antibody for the treatment of cachexia","volume":"85","author":"He","year":"2025","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.jpet.2026.105036_bib112","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat Med"},{"issue":"Suppl 8","key":"10.1016\/j.jpet.2026.105036_bib113","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1158\/1538-7445.AM2025-4258","article-title":"FL-501 is a potential best in class GDF-15 inhibitor with extended half-life and potent anti-cachexia activity in preclinical models","volume":"85","author":"Foster","year":"2025","journal-title":"Cancer Res"},{"issue":"6_Supplement","key":"10.1016\/j.jpet.2026.105036_bib114","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1538-7445.AM2024-1867","article-title":"Abstract 1867: LBL-049: a novel neutralizing antibody against GDF15 for the treatment of cachexia","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res"},{"issue":"12_Supplement","key":"10.1016\/j.jpet.2026.105036_bib115","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1158\/1538-7445.AM2022-5301","article-title":"Abstract 5301: GDF-15 neutralizing antibody restores cancer-induced cachexia","volume":"82","author":"Wu","year":"2022","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.jpet.2026.105036_bib116","doi-asserted-by":"crossref","first-page":"21441","DOI":"10.1021\/acs.jmedchem.5c01378","article-title":"Design of bicyclic peptide tandems mimicking the homodimeric GDF15 protein to inhibit GDF15-GFRaL-RET complex cell signaling","volume":"68","author":"Noisier","year":"2025","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-51932-x","article-title":"Structure-guided identification of small molecules potentially able to modulate GDF15 activity","volume":"16","author":"Chiariello","year":"2026","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.jpet.2026.105036_bib118","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.jpet.2026.105036_bib119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpet.2026.105036_bib120","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.2147\/CMAR.S261585","article-title":"Cancer cachexia: definition, staging, and emerging treatments","volume":"12","author":"Ni","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"8","key":"10.1016\/j.jpet.2026.105036_bib121","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.jpet.2026.105036_bib122","article-title":"RIVER-mPDAC: a phase 2b\/3 study of ponsegromab for the treatment of cachexia in patients with metastatic pancreatic ductal adenocarcinoma receiving first-line chemotherapy","volume":"44","author":"Roeland","year":"2026","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105036_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40291-017-0308-6","article-title":"PD-L1 testing in guiding patient selection for PD-1\/PD-L1 inhibitor therapy in lung cancer","volume":"22","author":"Ancevski Hunter","year":"2018","journal-title":"Mol Diagn Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652601236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652601236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:14:15Z","timestamp":1792145655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652601236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":117,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S002235652601236X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105036","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From stress cytokine to drug target: The translational landscape of growth differentiation factor 15","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"105036"}}